According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.
Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.
The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.
Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.
This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.
Related Stories
Parkway Radiology Deploys Annalise.ai Chest X-ray AI Solution
Parkway Radiology has implemented the Annalise.ai Enterprise CXR solution across all its radiology clinics and hospital departments in Singapore. This represents the first network-wide deployment of the chest X-ray AI technology in the country.
Fortis Enhances Diagnostic and Paediatric Care at S L Raheja Hospital, Mumbai
S L Raheja Hospital, a Fortis Associate, has significantly expanded its diagnostic and paediatric capabilities with the launch of AI-enabled Digital Positron Emission Tomography–Computed Tomography (PET-CT), 3 Tesla Magnetic Resonance Imaging (MRI), and upgraded Neonatal Intensive Care Unit (NICU) and Paediatric Intensive Care Unit (PICU) services.
Lace Up for a Cause: Gleneagles JPMC Kicks Off Registration for World Heart Day Brunei Run 2025
On 4 June 2025, Gleneagles JPMC officially open registrations for World Heart Day Brunei Run 2025 to champion cardiovascular health awareness
Acibadem Achieves Top Honours in Türkiye’s 2025 Industry Rankings
Acıbadem Healthcare Group continues to solidify its leadership in Türkiye’s healthcare sector, earning prestigious accolades in two major 2025 industry surveys.
Pantai Hospital Sungai Petani Takes Crown Again at ‘RecycleNow’ Competition
At Pantai Hospital Sungai Petani, sustainability is a practice embedded in our daily operations and a commitment to sustainable healthcare.
Gleneagles JPMC Advances Cardiac Care in Asia with Next-Gen Imaging System
In a significant move towards transforming cardiac care in Brunei and the region, Gleneagles JPMC has introduced a next-generation biplane cardiac imaging system by Philips.
